Statistics for Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies
Total visits
| views | |
|---|---|
| Long-term safety and efficacy of rilpivirine in combination with nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected patients: 336-week rollover study of phase 2b and 3 clinical studies | 1 |
Total visits per month
| views | |
|---|---|
| marzo 2024 | 0 |
| abril 2024 | 0 |
| mayo 2024 | 1 |
| junio 2024 | 0 |
| julio 2024 | 0 |
| agosto 2024 | 0 |
| septiembre 2024 | 0 |
File Visits
| views | |
|---|---|
| 196_molina-et-al-2021-long-term-safety-and-efficacy-of-rilpivirine-in-combination-with-nucleoside-nucleotide-reverse.pdf | 3 |